| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
ArfGAP with FG repeats 1 | 0.569 | 0.769 | 0.99 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
AKT serine/threonine kinase 1 | 0.311 | 0.962 | 0.98 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
albumin | 0.317 | 0.962 | 0.64 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2018 | 2019 | ||||||||
|
angiopoietin 2 | 0.410 | 0.846 | 0.83 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
Rho guanine nucleotide exchange factor 7 | 0.486 | 0.846 | 1.00 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
caspase 2 | 0.565 | 0.731 | 1.5E-03 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
CBFA2/RUNX1 partner transcriptional co-repressor 2 | 0.615 | 0.654 | 1.00 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
Cbl proto-oncogene like 2 | 0.476 | 0.808 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | |||||||||
|
C-C motif chemokine ligand 21 | 0.502 | 0.769 | 3.6E-02 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
C-C motif chemokine ligand 5 | 0.403 | 0.885 | 1.8E-03 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2005 | 2005 | ||||||||
|
cholesterol 25-hydroxylase | 0.663 | 0.577 | 0.23 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
cholinergic receptor nicotinic alpha 4 subunit | 0.492 | 0.808 | 8.5E-05 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
colony stimulating factor 2 | 0.330 | 0.962 | 0.83 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
C-X-C motif chemokine ligand 10 | 0.378 | 0.885 | 0.37 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2005 | 2005 | ||||||||
|
C-X-C motif chemokine ligand 13 | 0.472 | 0.731 | 0.83 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
cytochrome P450 family 1 subfamily A member 2 | 0.494 | 0.923 | 2.5E-10 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
cytochrome P450 family 2 subfamily C member 9 | 0.506 | 0.885 | 1.3E-10 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
cytochrome P450 family 2 subfamily D member 6 | 0.437 | 0.885 | 1.1E-25 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
cytochrome P450 family 3 subfamily A member 4 | 0.462 | 0.885 | 5.8E-11 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
dermcidin | 0.619 | 0.654 | 1.6E-04 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
DNL-type zinc finger | 0.663 | 0.538 | 2.5E-04 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 1985 | 2010 | ||||||||
|
dual specificity phosphatase 5 | 0.597 | 0.654 | 3.3E-03 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
EGF like, fibronectin type III and laminin G domains | 0.743 | 0.462 | 3.8E-19 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2016 | 2017 | ||||||||
|
enolase superfamily member 1 | 0.617 | 0.654 | 9.0E-19 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2009 | 2020 | ||||||||
|
EPH receptor A3 | 0.497 | 0.692 | 1.2E-05 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 |